Acute Pioglitazone Intoxication in Rats: Lack of Protective Effect of Intravenous Lipid Emulsion—A Pilot Study
Journal of Applied Toxicology · 2026
DOI: 10.1002/jat.4939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2026. Verfasst von Abdullah Tasci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, University of Health Sciences Sultan 2. Abdülhamid Han Research and Training Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Pioglitazone, Fat Emulsions, Intravenous, Hypoglycemic Agents, Chemical and Drug Induced Liver Injury. Die Arbeit nennt 33 Literaturangaben. Gefördert von: University of Health Sciences, Turkey (Sağlık Bilimleri Üniversitesi, affiliated with the Ministry of Health of Turkey), University of Health Sciences Lahore.
Abstract (Originalsprache)
Intravenous lipid emulsion (ILE) is an established antidote for local anesthetic systemic toxicity and has been tested in various lipophilic drug intoxications, but its efficacy in pioglitazone toxicity remains unclear. This study evaluated the biochemical and histopathological effects of pioglitazone and the potential protective role of ILE in an animal model. Thirty‐two male Sprague–Dawley rats were randomly assigned to four groups ( n = 8): control, ILE (12.4 mL/kg, 20% IV), pioglitazone (PIO; ½ LD 50 , 1000 mg/kg), and PIO + ILE. ILE (or saline) was administered intravenously over ~2 min immediately after pioglitazone, with matched volume and duration. Animals were observed for 24 h with free access to food and water. At 24 h, rats were decapitated, and blood and tissue samples were analyzed. Pioglitazone induced significant hepatic and renal injury (both p < 0.001), while cardiac changes were minimal and nonsignificant. ILE administration did not reduce liver or kidney injury. The ILE‐only group showed higher renal injury versus controls ( p < 0.001). Serum biochemistry revealed increased BUN and creatinine in PIO + ILE compared with Control and ILE (adjusted p < 0.05), with no difference between PIO and PIO + ILE. ILE failed to reverse hepatic or renal injury in acute pioglitazone toxicity and was associated with potential nephrotoxic effects. These findings suggest limited utility of ILE for pioglitazone overdose, likely reflecting drug physicochemical properties (moderate lipophilicity and high protein binding) and timing/dosing constraints. Caution is warranted, particularly regarding renal effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency, University of Health Sciences Sultan 2. Abdülhamid Han Research and Training Hospital, Istanbul, Turkey.
- Department of Emergency, University of Health Sciences Fatih Sultan Mehmet Education and Research Hospital, Istanbul, Turkey.
ORCID-Profile: Abdullah Tasci, Ecem Deniz Kirkpantur Tasci, Cansu Arslan Turan, Tuba Cimilli Ozturk
Förderung
- University of Health Sciences, Turkey (Sağlık Bilimleri Üniversitesi, affiliated with the Ministry of Health of Turkey)
- University of Health Sciences Lahore
Zitieren
APA
Tasci, A., Tasci, E. D. K., Turan, C. A., & Ozturk, T. C. (2026). Acute Pioglitazone Intoxication in Rats: Lack of Protective Effect of Intravenous Lipid Emulsion—A Pilot Study. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4939
Vancouver
Tasci A, Tasci EDK, Turan CA, Ozturk TC. Acute Pioglitazone Intoxication in Rats: Lack of Protective Effect of Intravenous Lipid Emulsion—A Pilot Study. Journal of Applied Toxicology. 2026. doi:10.1002/jat.4939
BibTeX
@article{Tasci2026,
author = {Tasci, Abdullah and Tasci, Ecem Deniz Kirkpantur and Turan, Cansu Arslan and Ozturk, Tuba Cimilli},
title = {Acute Pioglitazone Intoxication in Rats: Lack of Protective Effect of Intravenous Lipid Emulsion—A Pilot Study},
journal = {Journal of Applied Toxicology},
year = {2026},
doi = {10.1002/jat.4939}
}
EUVIMED